In the LabFDA orders Zafgen to halt clinical trial for obesity drug By Robert Weisman — Boston GlobeDec. 3, 2015 Reprints Zafgen FDA orders Zafgen to halt clinical trial for obesity drug About the Author Reprints Robert Weisman — Boston Globe [email protected] @GlobeRobW Tags clinical trials FDA zafgen
Pharmalot Ed Silverman Pfizer is scolded by a U.K. trade group for remarks its CEO made about vaccination
A STAT Investigation Jonathan Wosen ‘I’m just disgusted’: How alleged sexual misconduct stole one student’s passion for academic science